Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Soft Tissue Tumor and/or Sarcoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT03468075
What this trial is testing

Gemcitabine Plus Ascorbate for Sarcoma in Adults

Who this might be right for
SarcomaSoft Tissue SarcomaUnresectable Soft Tissue Sarcoma+2 more
Mohammed Milhem, MBBS 10
Early research (Phase 1)Study completedNCT02982941
What this trial is testing

Enoblituzumab (MGA271) in Children With B7-H3-expressing Solid Tumors

Who this might be right for
NeuroblastomaRhabdomyosarcomaOsteosarcoma+3 more
MacroGenics 25
Testing effectiveness (Phase 2)UnknownNCT00036712
What this trial is testing

Light-Emitting Diode Therapy in Preventing Mucositis in Children Receiving Chemotherapy With or Without Radiation Therapy Before Bone Marrow Transplantation

Who this might be right for
Chronic Myeloproliferative DisordersKidney CancerLeukemia+9 more
Medical College of Wisconsin 80
Testing effectiveness (Phase 2)Study completedNCT00084630
What this trial is testing

Imatinib Mesylate in Treating Patients With Locally Recurrent or Metastatic Dermatofibrosarcoma Protuberans

Who this might be right for
Adult FibrosarcomaDermatofibrosarcoma ProtuberansRecurrent Adult Soft Tissue Sarcoma+1 more
National Cancer Institute (NCI) 40
Early research (Phase 1)Study completedNCT03150810
What this trial is testing

Study to Assess Safety, Tolerability and Clinical Activity of BGB-290 in Combination With Temozolomide (TMZ) in Participants With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Locally Advanced or Metastatic Solid Tumors
BeiGene 139
Testing effectiveness (Phase 2)Study completedNCT01804374
What this trial is testing

Phase II Open Label, Non-randomized Study of Sorafenib and Everolimus in Relapsed and Non-resectable Osteosarcoma

Who this might be right for
Metastatic OsteosarcomaRelapsed Osteosarcoma
Italian Sarcoma Group 38
Testing effectiveness (Phase 2)Study completedNCT02500797
What this trial is testing

Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Sarcoma That Cannot Be Removed by Surgery

Who this might be right for
Locally Advanced Bone SarcomaLocally Advanced Dedifferentiated LiposarcomaLocally Advanced Gastrointestinal Stromal Tumor+18 more
National Cancer Institute (NCI) 164
Testing effectiveness (Phase 2)Study completedNCT01027910
What this trial is testing

PCI-24781 in Combination With Doxorubicin to Treat Sarcoma

Who this might be right for
Sarcoma
Massachusetts General Hospital 20
Not applicableNot Yet RecruitingNCT07723235
What this trial is testing

Web-based Lifestyle Program, mHealth and EMA Intervention, to Improve Weight Loss in Rural Stage I-III Postmenopausal Breast and Endometrial Cancer Survivors, HERO-C Trial

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8+4 more
Ohio State University Comprehensive Cancer Center 90
Early research (Phase 1)Ended earlyNCT01469975
What this trial is testing

First in Man Study Investigating the Biodistribution, the Safety and Optimal Recommended Dose of a New Radiolabelled Monoclonal Antibody Targeting Frizzled Homolog 10

Who this might be right for
Sarcoma, Synovial
Centre Leon Berard 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT02568267
What this trial is testing

Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)

Who this might be right for
Breast CancerCholangiocarcinomaColorectal Cancer+13 more
Hoffmann-La Roche 534
Not applicableUnknownNCT03680430
What this trial is testing

Evaluation of Adaptive Radiation Therapy in Pre-operative or Exclusive Radiation Therapy for Limb Soft Tissues Sarcomas

Who this might be right for
Sarcoma, Soft Tissue
Institut Paoli-Calmettes 61
Testing effectiveness (Phase 2)Ended earlyNCT00002993
What this trial is testing

Combination Chemotherapy in Treating Patients With Recurrent or Advanced Cancer of the Uterus

Who this might be right for
Sarcoma
Gynecologic Oncology Group 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT03213704
What this trial is testing

Larotrectinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With NTRK Fusions (A Pediatric MATCH Treatment Trial)

Who this might be right for
Advanced Malignant Solid NeoplasmRecurrent EpendymomaRecurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor+30 more
National Cancer Institute (NCI) 9
Testing effectiveness (Phase 2)Study completedNCT02008877
What this trial is testing

SARC023: Ganetespib and Sirolimus in Patients With MPNST (Malignant Peripheral Nerve Sheath Tumors)

Who this might be right for
Malignant Peripheral Nerve Sheath Tumors (MPNST)Sarcoma
Sarcoma Alliance for Research through Collaboration 20
Large-scale testing (Phase 3)Study completedNCT00003212
What this trial is testing

Ifosfamide or Doxorubicin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma

Who this might be right for
Sarcoma
European Organisation for Research and Treatment of Cancer - EORTC 780
Testing effectiveness (Phase 2)Study completedNCT04794127
What this trial is testing

Study on Trabectedin in Combination With Pioglitazone in Patients Myxoid Liposarcomas With Stable Disease After T Alone.

Who this might be right for
Liposarcoma, MyxoidLiposarcoma, DedifferentiatedLiposarcoma, Round Cell
Mario Negri Institute for Pharmacological Research 10
Testing effectiveness (Phase 2)Ended earlyNCT03458728
What this trial is testing

Safety, Tolerability, Efficacy and Pharmacokinetics of Copanlisib in Pediatric Patients

Who this might be right for
Relapsed or Refractory Solid Tumors or Lymphoma in ChildrenNeuroblastomaOsteosarcoma+2 more
Bayer 31
Testing effectiveness (Phase 2)Study completedNCT04216953
What this trial is testing

MEK Inhibitor and a PDL1 Inhibitor Patients With Locally Advanced and/or Metastatic Soft Tissue Sarcoma

Who this might be right for
Sarcoma,Soft Tissue
Centre Leon Berard 229
Early research (Phase 1)Study completedNCT03139331
What this trial is testing

PAZIT Study for Children and Young Adults With Relapsed or Refractory Sarcoma

Who this might be right for
SarcomaRefractory Sarcoma
University of California, San Francisco 16
Next Page